Abstract
Fibromyalgia is a common but contested illness. Its definition and content have changed repeatedly in the 110 years of its existence. The most important change was the requirement for multiple tender points and extensive pain that arose in the 1980s, features that were not required previously. By 2010, a second shift occurred that excluded tender points, allowed less extensive pain, and placed reliance on patient-reported somatic symptoms and cognitive difficulties ('fibro fog') that had never been part of past definitions or content. Fibromyalgia is closely allied with and often indistinguishable from neurasthenia, a disorder of the late 19th and early 20th centuries that lost favour when it was perceived as being a psychological illness. Fibromyalgia's status as a 'real disease', rather than a psychocultural illness, is buttressed by social forces that include support from official criteria, patient and professional organizations, pharmaceutical companies, disability access, and the legal and academic communities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Wolfe, F. et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 33, 160–172 (1990).
Wolfe, F., Brähler, E., Hinz, A. & Häuser, W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res. 65, 777–785 (2013).
Ehrlich, G. E. Pain is real; fibromyalgia isn't. J. Rheumatol. 30, 1666–1667 (2003).
Barker, K. K. Listening to Lyrica: contested illnesses and pharmaceutical determinism. Soc. Sci. Med. 73, 833–842 (2011).
Conrad, P. & Barker, K. K. The social construction of illness. J. Health Soc. Behav. 51, S67–S79 (2010).
Barker, K. K. The Fibromyalgia Story: Medical Authority and Women's Worlds of Pain (Temple University Press, 2005).
Wolfe, F. Fibromyalgia wars. J. Rheumatol. 36, 671–678 (2009).
Arnold, L. M., Clauw, D. J. & McCarberg, B. H. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin. Proc. 86, 457–464 (2011).
Williams, D. A. & Clauw, D. J. Understanding fibromyalgia: lessons from the broader pain research community. J. Pain 10, 777–791 (2009).
Block, S. R. On the nature of rheumatism. Arthritis Care Res. 12, 129–138 (1999).
Hadler, N. M. “Fibromyalgia” and the medicalization of misery. J. Rheumatol. 30, 1668–1670 (2003).
Hadler, N. M. & Greenhalgh, S. Labeling woefulness: the social construction of fibromyalgia. Spine 30, 1–4 (2005).
Cohen, M. L. & Quintner, J. L. Fibromyalgia syndrome, a problem of tautology. Lancet 342, 906–909 (1993).
Cohen, M. L. & Quintner, J. L. The derailment of railway spine: a timely lesson for post-traumatic fibromyalgia syndrome. Pain Rev. 3, 181–202 (1996).
Cohen, M. L. & Quintner, J. L. Fibromyalgia syndrome and disability: a failed construct fails those in pain. Med. J. Aust. 168, 402–404 (1998).
Ehrlich, G. E. Fibromyalgia, a virtual disease. Clin. Rheumatol. 22, 8–11 (2003).
Gowers, W. R. A lecture on lumbago: its lessons and analogues. BMJ 1, 117–121 (1904).
Edgecombe, W. Visceral fibrositis. Proc. R. Soc. Med. 13, 14 (1920).
Freyberg, R. H. Non-articular rheumatism. Bull. NY Acad. Med. 27, 245–258 (1951).
Graham, W. The fibrositis syndrome. Bull. Rheum. Dis. 3, 33–34 (1953).
Traut, E. F. Fibrositis. J. Am. Geriatr. Soc. 16, 531–538 (1968).
Smythe, H. A. & Hollander, J. L. in Arthritis and Allied Conditions (Lea and Febiger, 1966).
Smythe, H. A. & Hollander, J. L. in Arthritis and Allied Conditions 965–968 (Lea and Febiger, 1972).
Moldofsky, H., Scarisbrick, P., England, R. & Smythe, H. Musculosketal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom. Med. 37, 341–351 (1975).
Moldofsky, H. & Scarisbrick, P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom. Med. 38, 35–44 (1976).
Smythe, H. A. & Moldofsky, H. Two contributions to understanding of the “fibrositis” syndrome. Bull. Rheum. Dis. 28, 928–931 (1977).
Yunus, M., Masi, A. T., Calabro, J. J., Miller, K. A. & Feigenbaum, S. L. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin. Arthritis Rheum. 11, 151–171 (1981).
Wolfe, F. & Cathey, M. A. The epidemiology of tender points: a prospective study of 1520 patients. J. Rheumatol. 12, 1164–1168 (1985).
Bennett, R. M. Fibrositis: misnomer for a common rheumatic disorder. West. J. Med. 134, 405–413 (1981).
Simms, R. W., Goldenberg, D. L., Felson, D. T. & Mason, J. H. Tenderness in 75 anatomic sites. Distinguishing fibromyalgia patients from controls. Arthritis Rheum. 31, 182–187 (1988).
Wolfe, F. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 62, 600–610 (2010).
Fietta, P. & Manganelli, P. Fibromyalgia and psychiatric disorders. Acta Biomed. 78, 88–95 (2007).
Wolfe, F., Michaud, K., Li, T. & Katz, R. S. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with RA, non-inflammatory rheumatic disorders, and fibromyalgia. J. Rheumatol. 37, 296–304 (2010).
Hahn, S. R., Thompson, K. S., Wills, T. A., Stern, V. & Budner, N. S. The difficult doctor–patient relationship: somatization, personality and psychopathology. J. Clin. Epidemiol. 47, 647–657 (1994).
Gordon, R. Psychological factor in rheumatism. BMJ 1, 1165–1169 (1939).
Halliday, J. L. Psychological factors in rheumatism, part II. BMJ 1, 264–269 (1937).
Boland, E. W. Psychogenic rheumatism: the musculoskeletal expression of psychoneurosis. Ann. Rheum. Dis. 6, 195–203 (1947).
Reynolds, M. D. Clinical diagnosis of psychogenic rheumatism. West. J. Med. 128, 285–290 (1978).
Bennett, R. M. Nonarticular rheumatism and spondyloarthropathies. Similarities and differences. Postgrad. Med. 87, 97–99; 102–104 (1990).
Wolfe, F. & Rasker, J. J. in Kelley's Textbook of Rheumatology (eds Firestein, G. S. et al.) 555–570 (Elsevier, 2008).
Shorter, E. From Paralysis to Fatigue: A History of Psychosomatic Illness in the Modern Era (Free Press, 1993).
Taylor, R. E. Death of neurasthenia and its psychological reincarnation. A study of neurasthenia at the National Hospital for the Relief and Cure of the Paralysed and Epileptic, Queen Square, London, 1870–1932. Brit. J. Psychiatry 179, 550–557 (2001).
Wessely, S. Old wine in new bottles: neurasthenia and “M. E.”. Psychol. Med. 20, 35–53 (1990).
Beard, G. Neurasthenia, or nervous exhaustion. Boston Med. Sur. J. 80, 217–221 (1869).
Keller, T. Railway spine revisited: traumatic neurosis or neurotrauma? J. Hist. Med. Allied Sci. 50, 507–524 (1995).
Brown, P. et al. Embodied health movements: new approaches to social movements in health. Sociol. Health Illn. 26, 50–80 (2004).
Barker, K. K. Electronic support groups, patient-consumers, and medicalization: the case of contested illness. J. Health Soc. Behav. 49, 20–36 (2008).
McLean, S. A., Clauw, D. J., Abelson, J. L. & Liberzon, I. The development of persistent pain and psychological morbidity after motor vehicle collision: integrating the potential role of stress response systems into a biopsychosocial model. Psychosom. Med. 67, 783–790 (2005).
McLean, S. A., Williams, D. A. & Clauw, D. J. Fibromyalgia after motor vehicle collision: evidence and implications. Traffic Inj. Prev. 6, 97–104 (2005).
Häuser, W., Petzke, F. & Sommer, C. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J. Pain 11, 505–521 (2010).
Michel, J.-B. et al. Quantitative analysis of culture using millions of digitized books. Science 331, 176–182 (2011).
Author information
Authors and Affiliations
Contributions
Both authors contributed to all aspects of this manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Wolfe, F., Walitt, B. Culture, science and the changing nature of fibromyalgia. Nat Rev Rheumatol 9, 751–755 (2013). https://doi.org/10.1038/nrrheum.2013.96
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2013.96
This article is cited by
-
Are OMERACT recommendations followed in clinical trials on fibromyalgia? A systematic review of patient-reported outcomes and their measures
Quality of Life Research (2023)
-
The puzzle of fibromyalgia between central sensitization syndrome and small fiber neuropathy: a narrative review on neurophysiological and morphological evidence
Neurological Sciences (2022)
-
Nociplastic pain concept, a mechanistic basis for pragmatic approach to fibromyalgia
Clinical Rheumatology (2022)
-
Implication of invalidation concept in fibromyalgia diagnosis
Clinical Rheumatology (2021)
-
Two sides on the fibromyalgia coin: physical pain and social pain (invalidation)
Clinical Rheumatology (2021)